Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Super-resolution x-ray phase-contrast and dark-field imaging with a single 2D grating and electromagnetic source stepping.

Rix KR, Dreier T, Shen T, Bech M.

Phys Med Biol. 2019 Aug 14;64(16):165009. doi: 10.1088/1361-6560/ab2ff5.

PMID:
31284279
2.

NIR sensor for aqueous urea solution film thickness and concentration measurement using a broadband light source.

Lubnow M, Dreier T, Schulz C.

Appl Opt. 2019 Jun 1;58(16):4546-4552. doi: 10.1364/AO.58.004546.

PMID:
31251270
3.

Excitation wavelength dependence of the fluorescence lifetime of anisole.

Baranowski T, Dreier T, Schulz C, Endres T.

Phys Chem Chem Phys. 2019 Jul 10;21(27):14562-14570. doi: 10.1039/c9cp01472a.

PMID:
31232408
4.

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.

Howard JF Jr, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, Ward ES, Dreier T, Ulrichts P, Verschueren K, Guglietta A, de Haard H, Leupin N, Verschuuren JJGM; Efgartigimod MG Study Group.

Neurology. 2019 Jun 4;92(23):e2661-e2673. doi: 10.1212/WNL.0000000000007600. Epub 2019 May 22.

PMID:
31118245
5.

Laser applications to chemical, security, and environmental analysis: introduction to the feature issue.

Kiefer J, Seeger T, Dreier T, Chen W, Stauffer H, Meier W.

Appl Opt. 2019 Apr 1;58(10):LAC1-LAC3. doi: 10.1364/AO.58.00LAC1.

PMID:
31045083
6.

Water film thickness imaging based on time-multiplexed near-infrared absorption.

Lubnow M, Jeffries JB, Dreier T, Schulz C.

Opt Express. 2018 Aug 6;26(16):20902-20912. doi: 10.1364/OE.26.020902.

PMID:
30119397
7.

Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans.

Ulrichts P, Guglietta A, Dreier T, van Bragt T, Hanssens V, Hofman E, Vankerckhoven B, Verheesen P, Ongenae N, Lykhopiy V, Enriquez FJ, Cho J, Ober RJ, Ward ES, de Haard H, Leupin N.

J Clin Invest. 2018 Oct 1;128(10):4372-4386. doi: 10.1172/JCI97911. Epub 2018 Jul 24.

8.

Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.

Pascal KE, Dudgeon D, Trefry JC, Anantpadma M, Sakurai Y, Murin CD, Turner HL, Fairhurst J, Torres M, Rafique A, Yan Y, Badithe A, Yu K, Potocky T, Bixler SL, Chance TB, Pratt WD, Rossi FD, Shamblin JD, Wollen SE, Zelko JM, Carrion R Jr, Worwa G, Staples HM, Burakov D, Babb R, Chen G, Martin J, Huang TT, Erlandson K, Willis MS, Armstrong K, Dreier TM, Ward AB, Davey RA, Pitt MLM, Lipsich L, Mason P, Olson W, Stahl N, Kyratsous CA.

J Infect Dis. 2018 Nov 22;218(suppl_5):S612-S626. doi: 10.1093/infdis/jiy285.

9.

Application of toluene LIF to transonic nozzle flows to identify zones of incomplete molecular mixing.

Beuting M, Richter J, Weigand B, Dreier T, Schulz C.

Opt Express. 2018 Apr 16;26(8):10266-10273. doi: 10.1364/OE.26.010266.

PMID:
29715965
10.

Sequential signal detection for high dynamic range time-resolved laser-induced incandescence.

Mansmann R, Thomson K, Smallwood G, Dreier T, Schulz C.

Opt Express. 2017 Feb 6;25(3):2413-2421. doi: 10.1364/OE.25.002413.

PMID:
29519087
11.

Instantaneous 3D imaging of highly turbulent flames using computed tomography of chemiluminescence.

Mohri K, Görs S, Schöler J, Rittler A, Dreier T, Schulz C, Kempf A.

Appl Opt. 2017 Sep 10;56(26):7385-7395. doi: 10.1364/AO.56.007385.

PMID:
29048060
12.

Performance of photomultipliers in the context of laser-induced incandescence.

Mansmann R, Dreier T, Schulz C.

Appl Opt. 2017 Oct 1;56(28):7849-7860. doi: 10.1364/AO.56.007849.

PMID:
29047769
13.

Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions.

Beirnaert E, Desmyter A, Spinelli S, Lauwereys M, Aarden L, Dreier T, Loris R, Silence K, Pollet C, Cambillau C, de Haard H.

Front Immunol. 2017 Jul 31;8:867. doi: 10.3389/fimmu.2017.00867. eCollection 2017.

14.

Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies.

Aftimos P, Rolfo C, Rottey S, Offner F, Bron D, Maerevoet M, Soria JC, Moshir M, Dreier T, Van Rompaey L, Michot JM, Silence K, Hultberg A, Gandini D, de Haard H, Ribrag V, Peeters M, Thibault A, Leupin N, Awada A.

Clin Cancer Res. 2017 Nov 1;23(21):6411-6420. doi: 10.1158/1078-0432.CCR-17-0613. Epub 2017 Aug 1.

15.

Laser applications to chemical, security, and environmental analysis: introduction to the feature issue.

Seeger T, Dreier T, Chen W, Kearny S, Kulatilaka W.

Appl Opt. 2017 Apr 10;56(11):LAC1-LAC3. doi: 10.1364/AO.56.00LAC1.

PMID:
28414389
16.

Laser-induced atomic emission of silicon nanoparticles during laser-induced heating.

Menser J, Daun K, Dreier T, Schulz C.

Appl Opt. 2017 Apr 10;56(11):E50-E57. doi: 10.1364/AO.56.000E50.

PMID:
28414341
17.

Uncertainty quantification and design-of-experiment in absorption-based aqueous film parameter measurements using Bayesian inference.

Pan R, Daun KJ, Dreier T, Schulz C.

Appl Opt. 2017 Apr 10;56(11):E1-E7. doi: 10.1364/AO.56.0000E1.

PMID:
28414335
18.

Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics.

Klarenbeek A, Blanchetot C, Schragel G, Sadi AS, Ongenae N, Hemrika W, Wijdenes J, Spinelli S, Desmyter A, Cambillau C, Hultberg A, Kretz-Rommel A, Dreier T, De Haard HJ, Roovers RC.

Protein Eng Des Sel. 2016 Apr;29(4):123-33. doi: 10.1093/protein/gzw003. Epub 2016 Mar 5.

PMID:
26945588
19.

Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling.

Hultberg A, Morello V, Huyghe L, De Jonge N, Blanchetot C, Hanssens V, De Boeck G, Silence K, Festjens E, Heukers R, Roux B, Lamballe F, Ginestier C, Charafe-Jauffret E, Maina F, Brouckaert P, Saunders M, Thibault A, Dreier T, de Haard H, Michieli P.

Cancer Res. 2015 Aug 15;75(16):3373-83. doi: 10.1158/0008-5472.CAN-15-0356. Epub 2015 Jul 3.

20.

Radicals Are Required for Thiol Etching of Gold Particles.

Dreier TA, Ackerson CJ.

Angew Chem Int Ed Engl. 2015 Aug 3;54(32):9249-52. doi: 10.1002/anie.201502934. Epub 2015 Jun 18.

21.

Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents.

King JC Jr, Gao Y, Quinn CP, Dreier TM, Vianney C, Espeland EM.

Vaccine. 2015 May 15;33(21):2470-6. doi: 10.1016/j.vaccine.2015.03.071. Epub 2015 Apr 5.

PMID:
25850022
22.

Oxidative decomposition of Au25(SR)18 clusters in a catalytic context.

Dreier TA, Wong OA, Ackerson CJ.

Chem Commun (Camb). 2015 Jan 25;51(7):1240-3. doi: 10.1039/c4cc07832b.

PMID:
25472705
23.

Four individually druggable MET hotspots mediate HGF-driven tumor progression.

Basilico C, Hultberg A, Blanchetot C, de Jonge N, Festjens E, Hanssens V, Osepa SI, De Boeck G, Mira A, Cazzanti M, Morello V, Dreier T, Saunders M, de Haard H, Michieli P.

J Clin Invest. 2014 Jul;124(7):3172-86. doi: 10.1172/JCI72316. Epub 2014 May 27.

24.

An automated thermophoretic soot sampling device for laboratory-scale high-pressure flames.

Leschowski M, Dreier T, Schulz C.

Rev Sci Instrum. 2014 Apr;85(4):045103. doi: 10.1063/1.4868970.

PMID:
24784655
25.

Formaldehyde laser-induced fluorescence imaging with a multi-band transmission filter.

Thering H, Beckmann L, Jördens C, Röder M, Dreier T, Schulz C.

Opt Lett. 2014 Apr 1;39(7):1873-6. doi: 10.1364/OL.39.001873.

PMID:
24686627
26.

ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.

Silence K, Dreier T, Moshir M, Ulrichts P, Gabriels SM, Saunders M, Wajant H, Brouckaert P, Huyghe L, Van Hauwermeiren T, Thibault A, De Haard HJ.

MAbs. 2014 Mar-Apr;6(2):523-32. doi: 10.4161/mabs.27398. Epub 2013 Dec 6.

27.

Recommendations to improve collaboration and expedite acceptance of animal models.

Stundick MV, Albrecht MT, Houchens CR, Smith AP, Dreier TM, Larsen JC.

Vet Pathol. 2013 Sep;50(5):893-4. doi: 10.1177/0300985813486815. No abstract available.

PMID:
24014613
28.

Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule.

Stundick MV, Albrecht MT, Houchens CR, Smith AP, Dreier TM, Larsen JC.

Vet Pathol. 2013 Sep;50(5):877-92. doi: 10.1177/0300985813486812. Epub 2013 Apr 29. Review.

PMID:
23628693
29.

In-cylinder temperature measurements via time-correlated single-photon counting of toluene laser-induced fluorescence through a fiber-based sensor.

Friesen E, Gessenhardt C, Kaiser SA, Dreier T, Schulz C.

Opt Lett. 2012 Dec 15;37(24):5244-6. doi: 10.1364/OL.37.005244.

PMID:
23258066
30.

Legal aspects of service robotics.

Dreier T, Spiecker Genannt Döhmann I.

Poiesis Prax. 2012 Dec;9(3-4):201-217. Epub 2012 Nov 27.

31.

Service robotics: do you know your new companion? Framing an interdisciplinary technology assessment.

Decker M, Dillmann R, Dreier T, Fischer M, Gutmann M, Ott I, Spiecker Genannt Döhmann I.

Poiesis Prax. 2011 Nov;8(1):25-44. Epub 2011 Nov 3.

32.

Palladium-catalyzed elimination/isomerization of enol triflates into 1,3-dienes.

Crouch IT, Dreier T, Frantz DE.

Angew Chem Int Ed Engl. 2011 Jun 27;50(27):6128-32. doi: 10.1002/anie.201101820. Epub 2011 May 13. No abstract available.

PMID:
21574234
33.

Laser-based diagnostics for the measurement of liquid water film thickness.

Greszik D, Yang H, Dreier T, Schulz C.

Appl Opt. 2011 Feb 1;50(4):A60-7. doi: 10.1364/AO.50.000A60.

PMID:
21283221
34.

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis.

Vandenbroucke K, de Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P.

Mucosal Immunol. 2010 Jan;3(1):49-56. doi: 10.1038/mi.2009.116. Epub 2009 Sep 30.

PMID:
19794409
35.

Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology.

Tijink BM, Laeremans T, Budde M, Stigter-van Walsum M, Dreier T, de Haard HJ, Leemans CR, van Dongen GA.

Mol Cancer Ther. 2008 Aug;7(8):2288-97. doi: 10.1158/1535-7163.MCT-07-2384.

37.

Polarization-dependent laser-induced grating measurements.

Rozouvan S, Dreier T.

Opt Lett. 1999 Nov 15;24(22):1596-8.

PMID:
18079875
38.

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis.

Coppieters K, Dreier T, Silence K, de Haard H, Lauwereys M, Casteels P, Beirnaert E, Jonckheere H, Van de Wiele C, Staelens L, Hostens J, Revets H, Remaut E, Elewaut D, Rottiers P.

Arthritis Rheum. 2006 Jun;54(6):1856-66.

39.
40.

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct.

Schlereth B, Quadt C, Dreier T, Kufer P, Lorenczewski G, Prang N, Brandl C, Lippold S, Cobb K, Brasky K, Leo E, Bargou R, Murthy K, Baeuerle PA.

Cancer Immunol Immunother. 2006 May;55(5):503-14. Epub 2005 Jul 20.

PMID:
16032400
42.

Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells.

Xiang W, Wimberger P, Dreier T, Diebold J, Mayr D, Baeuerle PA, Kimmig R.

J Cancer Res Clin Oncol. 2003 Jun;129(6):341-8. Epub 2003 Jun 18.

PMID:
12819960
43.

Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivo.

Zocher M, Baeuerle PA, Dreier T, Iglesias A.

Int Immunol. 2003 Jul;15(7):789-96.

PMID:
12807817
44.

Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct.

Löffler A, Gruen M, Wuchter C, Schriever F, Kufer P, Dreier T, Hanakam F, Baeuerle PA, Bommert K, Karawajew L, Dörken B, Bargou RC.

Leukemia. 2003 May;17(5):900-9.

PMID:
12750704
45.

T cell costimulus-independent and very efficacious inhibition of tumor growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19-/CD3- bispecific single-chain antibody construct.

Dreier T, Baeuerle PA, Fichtner I, Grün M, Schlereth B, Lorenczewski G, Kufer P, Lutterbüse R, Riethmüller G, Gjorstrup P, Bargou RC.

J Immunol. 2003 Apr 15;170(8):4397-402.

46.

Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody.

Wimberger P, Xiang W, Mayr D, Diebold J, Dreier T, Baeuerle PA, Kimmig R.

Int J Cancer. 2003 Jun 10;105(2):241-8.

47.

Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody.

Dreier T, Lorenczewski G, Brandl C, Hoffmann P, Syring U, Hanakam F, Kufer P, Riethmuller G, Bargou R, Baeuerle PA.

Int J Cancer. 2002 Aug 20;100(6):690-7.

48.

In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment.

Naundorf S, Preithner S, Mayer P, Lippold S, Wolf A, Hanakam F, Fichtner I, Kufer P, Raum T, Riethmüller G, Baeuerle PA, Dreier T.

Int J Cancer. 2002 Jul 1;100(1):101-10.

49.

High-throughput generation and engineering of recombinant human antibodies.

Krebs B, Rauchenberger R, Reiffert S, Rothe C, Tesar M, Thomassen E, Cao M, Dreier T, Fischer D, Höss A, Inge L, Knappik A, Marget M, Pack P, Meng XQ, Schier R, Söhlemann P, Winter J, Wölle J, Kretzschmar T.

J Immunol Methods. 2001 Aug 1;254(1-2):67-84.

PMID:
11406154
50.

Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases.

Xiang R, Lode HN, Dreier T, Gillies SD, Reisfeld RA.

Cancer Res. 1998 Sep 1;58(17):3918-25.

Supplemental Content

Loading ...
Support Center